CF
MDGL icon

CNA Financial’s Madrigal Pharmaceuticals MDGL Stock Holding History

CNA Financial’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,010
Closed -$223K – 207
2020
Q4 		$223K Sell
2,010
-1,230
-38% -$150K 0.07% 188
2020
Q3 		$385K Buy
3,240
+360
+13% +$39.1K 0.14% 152
2020
Q2 		$326K Buy
+2,880
New +$283K 0.13% 160

Other funds holding MDGL

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

CNA Financial's MDGL Position: Q1 2021 in Review

CNA Financial sold out of Madrigal Pharmaceuticals (MDGL) in Q1 2021, closing a stake of 2,010 shares — an estimated $223K sold.

CNA Financial first reported a position in MDGL in Q2 2020 and held it in 3 quarters. The position peaked at $385K in Q3 2020. 137 funds tracked by Wall St. Rank hold MDGL as of Q1 2021.

  • CNA Financial reported no remaining Madrigal Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • CNA Financial sold 2,010 Madrigal Pharmaceuticals shares in Q1 2021, an estimated $223K.
  • CNA Financial first reported a position in Madrigal Pharmaceuticals in Q2 2020 and held it in 3 quarters.
  • CNA Financial's Madrigal Pharmaceuticals position peaked at $385K in Q3 2020.
  • 137 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2021.

Based on CNA Financial's 13F filing for Q1 2021, filed 14 May 2021.